Continuum Advisory’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$83.2K Buy
+297
New +$78.1K 0.01% 676
2025
Q2
Sell
-23
Closed -$5.35K 1079
2025
Q1
$5.35K Sell
23
-9
-28% -$2.18K ﹤0.01% 1099
2024
Q4
$7.34K Buy
32
+3
+10% +$688 ﹤0.01% 1056
2024
Q3
$6.91K Buy
29
+7
+32% +$1.54K ﹤0.01% 1085
2024
Q2
$4.48K Buy
22
+2
+10% +$407 ﹤0.01% 1099
2024
Q1
$4.12K Sell
20
-914
-98% -$201K ﹤0.01% 1104
2023
Q4
$212K Sell
934
-142
-13% -$29.8K 0.03% 434
2023
Q3
$216K Sell
1,076
-671
-38% -$142K 0.03% 415
2023
Q2
$362K Sell
1,747
-5
-0.3% -$970 0.06% 333
2023
Q1
$345K Buy
1,752
+44
+3% +$9.05K 0.06% 324
2022
Q4
$345K Sell
1,708
-383
-18% -$74.9K 0.06% 321
2022
Q3
$368K Sell
2,091
-192
-8% -$39.3K 0.06% 291
2022
Q2
$460K Buy
2,283
+444
+24% +$94.6K 0.08% 264
2022
Q1
$380K Buy
+1,839
New +$433K 0.07% 280
2018
Q4
Sell
-1,581
Closed -$236K 167
2018
Q3
$236K Buy
1,581
+112
+8% +$17K 0.16% 133
2018
Q2
$227K Sell
1,469
-31
-2% -$4.68K 0.17% 127
2018
Q1
$208K Buy
+1,500
New +$220K 0.17% 129

Other funds holding LH

Continuum Advisory's LH Position: Q2 2026 in Review

Continuum Advisory opened a new position in Labcorp (LH) in Q2 2026: 297 shares worth $83.2K. The stake represents 0.01% of the portfolio and ranks #676 among its holdings. This is a return to the name: Continuum Advisory previously reported a position in LH as recently as Q1 2025.

Continuum Advisory first reported a position in LH in Q1 2018 and has held it in 17 quarters since. The position peaked at $460K in Q2 2022. 1,058 funds tracked by Wall St. Rank hold LH as of Q2 2026.

  • Continuum Advisory held 297 shares of Labcorp worth $83.2K as of Q2 2026.
  • Labcorp was a new Continuum Advisory position in Q2 2026.
  • Labcorp made up 0.01% of Continuum Advisory's portfolio in Q2 2026, its #676 holding.
  • Continuum Advisory first reported a position in Labcorp in Q1 2018 and has held it in 17 quarters since.
  • Continuum Advisory's Labcorp position peaked at $460K in Q2 2022.
  • 1,058 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on Continuum Advisory's 13F filing for Q2 2026, filed 6 Aug 2026.